Last checked at 18 Jan 2017 16:30
For immediate release | 18 January 2017 |
Futura Medical plc
("Futura" or the "Company")
Director's dealings
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that it has today received notification that James Barder, the Chief Executive of the Company, has gifted in aggregate 50,000 ordinary shares in the Company to a shareholding account jointly held by his children.
Following the transfer, Mr. Barder's revised aggregate beneficial and non-beneficial holding is 1,478,830 ordinary shares, representing 1.23 per cent. of the Company's issued share capital.
Further details are contained within the notification below, made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.
For further information:
Futura Medical plc |
+ 44 (0) 1483 685 670 |
James Barder, Chief Executive | |
Mail to: James.Barder@futuramedical.com | www.futuramedical.com |
N+1 Singer |
+44 (0) 20 7496 3000 |
Aubrey Powell / Liz Yong Brough Ransom - Sales | |
Buchanan |
+ 44 (0) 20 7466 5000 |
Mark Court / Sophie Cowles / Stephanie Watson |
Notes to editors:
About Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange (AIM: FUM).
www.futuramedical.com
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| James Barder | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Director/ PDMR | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Futura Medical plc | ||||
b)
| LEI
| 21380053QLT46UNV2303 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares of 0.2p each
GB0033278473 | ||||
b)
| Nature of the transaction
| Transfer of shares to joint account of adult children (not PCAs) | ||||
c)
| Prices and volumes
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
Not applicable
| ||||
e)
| Date of the transaction
| 17 January 2017 | ||||
f)
| Place of the transaction
| Outside a trading venue | ||||